Dapagliflozin versus sacubitril–valsartan for heart failure with mildly reduced or preserved ejection fraction

Overview of attention for article published in Frontiers in Pharmacology, March 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,856 followers.

New Research: Dapagliflozin versus sacubitril–valsartan for heart failure with mildly reduced or preserved ejection fraction https://t.co/LPhKPTA6KW #pharmacology

19 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.